How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

13,730 results for

Ages and Stages Questionnaire

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Evaluation of Eat Well Keep Active (Stage 2)

Evaluation of Eat Well Keep Active (Stage 2) December 2016 Evaluation of Eat Well Keep Active (Stage 2)Eat Well Keep Active Report Stage 2 2016 Roma Robertson and Dr Ruth Jepson, SCPHRP This report describes the findings of a prospective evaluation involving participants in two CHANGES Eat Well – Keep Active courses (starting in November 2013 and June 2014). Acknowledgements We would like to thank all the Eat Well – Keep Active Course attendees who completed our questionnaires. We would also (...) of effects seen in Stage 1 • determine whether these effects were maintained over the longer term • determine which effects are maintained over the longer term and which are not. 6Eat Well Keep Active Report Stage 2 2016 MethodsEat Well Keep Active Report Stage 2 2016 This stage of the evaluation used quantitative (longitudinal postal questionnaires) methods. The Stage 1 questionnaire was amended and piloted on an Eat Well - Keep Active course which started on June 6th 2013. The responses raised concerns

2016 Scottish Collaboration for Public Health Research & Policy

42. Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Capacity to consent to participate in the study as assessed using the Evaluation to Sign Consent tool and investigator judgment Age 25 to 65 years, inclusive, at the time of signing Informed Consent Form Early manifest, Stage I or Stage II HD (defined as TFC of 7-13, inclusive) Genetically confirmed disease (CAG repeat length ≥ 36 in huntingtin gene by direct DNA testing) Body mass index ≥18 and ≤32 kg/m2; total body weight >50 kg Ability (...) Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study

2018 Clinical Trials

43. Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA)

Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA) Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached (...) the maximum number of saved studies (100). Please remove one or more studies before adding more. Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA) (IBBR) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read

2018 Clinical Trials

44. A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer (...) to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer The safety and scientific validity of this study is the responsibility

2018 Clinical Trials

45. One-stage Versus Two-stage Revision of the Infected Knee Arthroplasty

One-stage Versus Two-stage Revision of the Infected Knee Arthroplasty One-stage Versus Two-stage Revision of the Infected Knee Arthroplasty - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. One-stage Versus (...) Two-stage Revision of the Infected Knee Arthroplasty The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03435679 Recruitment Status : Recruiting First Posted : February 16, 2018 Last Update Posted : March 6, 2018 See

2018 Clinical Trials

46. Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage. Full Text available with Trip Pro

Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage. This study evaluated the clinical and non-clinical determinants of health-related quality of life (HRQoL) associated with untreated chronic hepatitis C (CHC) in France.From 01/2014 to 01/2015, untreated CHC patients were invited to complete a questionnaire including EQ-5D utility instrument and two visual analogue scales (VAS) measuring overall health (...) and fatigue in three French centers (Paris, Lille and Montpellier). Answers were analyzed in mixed models (taking into account the clustering effects of centers and physicians).Five hundreds and five patients were enrolled: 52% males; the mean age was 54; 41% had BMI>25; 64% had genotype 1; 36% were at the stage of severe fibrosis (F3-F4); 38% had severe comorbidities other than liver-related. In the univariate analysis, EQ-5D utility was associated with socio-demographic variables as age, place of birth

2019 PLoS ONE

47. Intake of key micronutrients and food groups in patients with late-stage age-related macular degeneration compared with age-sex-matched controls. (Abstract)

Intake of key micronutrients and food groups in patients with late-stage age-related macular degeneration compared with age-sex-matched controls. Knowledge of the risk factor profile of patients presenting with late-stage age-related macular degeneration (AMD) could help identify the most frequent modifiable AMD precursors among people who are referred for treatment. We aimed to assess dietary behaviours by comparing adjusted mean intakes of micronutrients and major food groups (fruits (...) -frequency questionnaire. AMD lesions were assessed from retinal photographs.After multivariable adjustment, patients with late-stage AMD compared with controls had significantly lower intakes of vitamin E (7.4 vs 9.8 mg/day; p<0.0001), beta-carotene (6232 vs 7738 μg/day; p<0.0001), vitamin C (161 vs 184 mg/day; p=0.0002) and folate (498.3 vs 602 μg/day; p<0.0001); but had higher intakes of zinc (13.0 vs 11.9 mg/day; p<0.0001). A significantly lower proportion of patients with late AMD met

2016 British Journal of Ophthalmology

48. Validity of the ages and stages questionnaires in term and preterm infants. Full Text available with Trip Pro

Validity of the ages and stages questionnaires in term and preterm infants. This study assessed the concurrent validity of the parent-completed developmental screening measure Ages and Stages Questionnaires, Third Edition (ASQ-3) compared with the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III) in children born term, late preterm, or extremely preterm at 8, 18, or 30 months of corrected gestational ages (CGA).Data were collected from 306 term and preterm children (...) ages 8, 18, and 30 months' CGA recruited from an ambulatory well-child clinic in Santiago, Chile. Parents completed the ASQ-3 in their homes, and afterward a trained professional administered the Bayley-III in a clinic setting. On the ASQ-3, the presence of any domain screened <2 SDs below the mean area score was considered a positive screen (indicating failure or delay). A Bayley-III score less than ≤1 SD indicated mild or severe delay.ASQ-3 showed adequate psychometric properties (75% sensitivity

2013 Pediatrics

49. The role of sentinel lymph node biopsy in the treatment of women with early stage vulval cancer: A summary of the evidence

with early stage vulval cancer: A systematic review. Sydney, 2014 9.Covens A, Vella ET, Kennedy EB, et al. Sentinel lymph node biopsy in vulvar cancer: Systematic review, meta-analysis and guideline recommendations. Gynecol Oncol. 2015;137(2):351-361 10.Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26(6):884-9 11.Oonk MH, van Os MA, de Bock GH, et al. A comparison of quality of life between vulvar cancer (...) The role of sentinel lymph node biopsy in the treatment of women with early stage vulval cancer: A summary of the evidence The role of sentinel lymph node biopsy in the treatment of women with early vulval cancer: A summary of the evidence Early-stage cancer of the vulva The International Federation of Gynaecology and Obstetrics (FIGO) categorises cancer of the vulva into stages, with early-stage (1A or 1B) defined as being confined to the vulva or perineum, with stromal invasion, and negative

2015 Cancer Australia

50. Left ventricular assist devices in the treatment of end-stage heart failure

– Survival of LVAD patients (by type of patient) BTC: bridge to candidacy; BTT: bridge to transplant; DT: destination therapy Source: INTERMACS registry, 2015 Q2 8 Left ventricular assist devices in the treatment of end-stage heart failure KCE Report 264Cs A better quality of life as well Patients who receive an LVAD also see a significant increase in their quality of life after the procedure, despite the possible complications (see section 2.2). This has been evaluated with various questionnaires (...) Left ventricular assist devices in the treatment of end-stage heart failure 2016 www.kce.fgov.be KCE REPORT 264Cs SYNTHESIS LEFT VENTRICULAR ASSIST DEVICES IN THE TREATMENT OF END-STAGE HEART FAILURE 2016 www.kce.fgov.be KCE REPORT 264Cs HEALTH TECHNOLOGY ASSESSMENT SYNTHESIS LEFT VENTRICULAR ASSIST DEVICES IN THE TREATMENT OF END-STAGE HEART FAILURE MATTIAS NEYT, ROOS LEROY, CARL DEVOS, HANS VAN BRABANDT KCE Report 264Cs Left ventricular assist devices in the treatment of end-stage heart

2016 Belgian Health Care Knowledge Centre

51. Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study Full Text available with Trip Pro

and validated chronic obstructive pulmonary disease questionnaire to increase the pre-test probability for chronic obstructive pulmonary disease diagnosis in subjects undergoing confirmatory spirometry. In 2005, we completed the Austrian Burden of Obstructive Lung Disease-study in 1258 subjects aged >40 years. Post-bronchodilator spirometry was performed, and non-reversible airflow limitation defined by FEV1/FVC ratio below the lower limit of normal. Questions from the Salzburg chronic obstructive pulmonary (...) obstructive pulmonary disease screening questionnaire was derived from the highly standardized Burden of Obstructive Lung Disease study. This validated and easy to use questionnaire can help to increase the efficiency of chronic obstructive pulmonary disease case-finding.QUESTIONNAIRE FOR PRE-SCREENING POTENTIAL SUFFERERS: Scientists in Austria have developed a brief, simple questionnaire to identify patients likely to have early-stage chronic lung disease. Chronic obstructive pulmonary disease (COPD

2017 NPJ primary care respiratory medicine

52. Ages and Stages Questionnaire

Ages and Stages Questionnaire Ages and Stages Questionnaire Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Ages and Stages (...) Questionnaire Ages and Stages Questionnaire Aka: Ages and Stages Questionnaire , ASQ Questionnaire From Related Chapters II. Indications Development screening for age 1 month up to 5.5 years old (19 questionnaires) III. Description Each questionnaire contains 6 questions each in 5 areas (30 questions total) Communication Gross motor Fine motor Problem solving Personal-social Each question asks if the child is performing the given skill Yes: 10 points Sometimes: 5 points Not yet: 0 points Matches well child

2015 FP Notebook

53. Ages and Stages Questionnaire Social Emotional

Ages and Stages Questionnaire Social Emotional Ages and Stages Questionnaire Social Emotional Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Ages and Stages Questionnaire Social Emotional Ages and Stages Questionnaire Social Emotional Aka: Ages and Stages Questionnaire Social Emotional , ASQ:SE Behavioral Questionnaire , ASQ:SE From Related Chapters II. Indications Behavioral Screening in preschool children III. Description Specific questionnaire for each age of administration: 6, 12, 18, 24, 30, 36, 48 and 60 months Questionnaire addresses 7 areas Self regulation Compliance Communication Adaptive functioning Autonomy Affect

2015 FP Notebook

54. Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings

to deter- mine the quality of evidence and strength of recommendation (Box 1). The evidence-to-decision framework is provided in Appendix 2 (available at www.cmaj.ca/lookup/suppl/doi:10.1503/ cmaj.171430/-/DC1). The Knowledge Translation team at St. Michael’s Hospital (Toronto, Ontario) engaged members of the public on behalf of the task force at two stages of guideline development. In the first phase, 15 participants aged 58 to 78 years rated outcomes to inform the systematic review, by means (...) Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings E588 CMAJ | MAY 14, 2018 | VOLUME 190 | ISSUE 19 © 2018 Joule Inc. or its licensors I mpaired vision is an important health burden in both devel- oped and developing countries, particularly among older adults. 1 The 2006 Participation and Activity Limitation Survey found that 13% of Canadians aged 75 years and older had a “see- ing limitation,” with 31% described as severe, compared

2018 CPG Infobase

55. Tiotropium (Spiriva Respimat) add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma

Tiotropium (Spiriva Respimat) add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma Tiotropium (Spiriva ® Respimat ® ). Reference number 1882. Page 1 of 3 AWMSG Secretariat Assessment Report – Limited submission Tiotropium (Spiriva ® Respimat ® ) 2.5 microgram, inhalation solution Company: Boehringer Ingelheim Ltd Licensed indication under consideration: add-on maintenance bronchodilator treatment in patients aged 6 years to < 18 years with severe (...) -on maintenance bronchodilator treatment in adult patients with asthma who are currently treated with the maintenance combination of inhaled corticosteroids (= 800 micrograms budesonide per day or equivalent) and long-acting ß2 agonists and who experienced one or more severe exacerbations in the previous year. This submission covers the licence extension to include patients aged 6 years to < 18 years. The whole licenced indication wording was revised at the time of the paediatric licence extension and is now

2018 All Wales Medicines Strategy Group

56. Using a bath or pool during first stage labour: A decision aid for women having a vaginal birth

Questionnaire. Journal of Nursing Research, 14(3): p. 190-197. [5] Brown, S.T., D. Campbell, and A. Kurtz, Characteristics of labor pain at two stages of cervical dilation. Pain, 1989. 39(3): p. 289-295. [6] Gaston-Johansson, f., G. Fridh, and K. Turner-Norvell, Progression of labor pain in primiparas and multiparas. Nursing Research, 1988. 37(2): p. 86-90. [7] Lowe, N.K., The nature of labor pain. American Journal of Obstetrics and Gynecology, 2002. 186(5, Supplement 1): p. S16-S24. [8] National (...) Using a bath or pool during first stage labour: A decision aid for women having a vaginal birth Using a bath or pool during first stage labour: A decision aid for women having a vaginal birthThis decision aid has been written to support women who are wanting to have a vaginal birth to know what to expect and to have a say in making decisions about using a bath or pool during labour. This decision aid provides information about two options: 1. Not using a bath or pool during labour 2 Using

2015 EUnetHTA

57. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) Full Text available with Trip Pro

Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) | Nephrology Dialysis Transplantation | Oxford (...) Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation May 2015 Article Contents Article Navigation Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) Guideline development group Search for other works by this author on: Henk Bilo Search for other works by this author on: Luis Coentrão Search

2015 European Renal Best Practice

58. A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record (...) managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (IMagyn050) The safety

2017 Clinical Trials

59. Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer

Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record (...) Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal

2017 Clinical Trials

60. Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment. Full Text available with Trip Pro

parameters.This was a cross-sectional and non-interventional multicentre study. SMM was assessed by analysing L3 computed tomography-scan images. Patients completed the anorexia/CAX subscale of the Functional Assessment of Anorexia/Cachexia Therapy, EORTC QLQ-C30 quality of life (QoL) and International Physical Activity Questionnaire (IPAQ).Patients were recruited in 56 sites. The analysis population comprised 531 patients, and SMM was assessed in 312 patients. Male patients were 66.5%, with a mean (SD) age (...) Activity Questionnaire (P < 0.001). Sarcopenia was present in 66.7% of CAX and 68.5% of pre-CAX patients. Overall, 43.8% of pre-CAX patients had only sarcopenia with limited weight loss (≤2%) and no anorexia.This is the first study to show the distribution of CAX in a population of NSCLC patients and an association between molecular abnormality in NSCLC and CAX. The original Fearon classification for CAX stages was supported by the associated functional QoL scores and physical activity levels

2019 Journal of cachexia, sarcopenia and muscle

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>